Stock Events

Stock Events

Organon

0

645

+$0.00+0% 00:00 Today

Statistics

Day High

-

Day Low

-

52W High

-

52W Low

-

Volume

-

Avg. Volume

-

Mkt Cap

0

P/E Ratio

-

Dividend Yield

-

Dividend

-

Earnings

11AugExpected

Q4 2024

Q1 2025

Q2 2025

Q3 2025

Q4 2025

Q1 2026

Q2 2026

0.63

0.76

0.88

1.01

Expected EPS

0.900811

Actual EPS

N/A

Financials

13.49%Profit Margin

Profitable

2019

2020

2021

2022

2023

2024

6.4BRevenue

864MNet Income

Analyst Ratings

14.00Average Price Target

The highest estimate is 14.00.
From 2 ratings within the last 6 months. This is not an investment recommendation.

Buy

0%

Hold

100%

Sell

0%

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

Pfizer is a global pharmaceutical company that competes with Organon in the areas of women's health and biosimilars, making it a direct competitor.

Merck, the former parent company of Organon, competes in the pharmaceutical sector, including women's health and vaccine products.

AbbVie competes with Organon in the pharmaceuticals sector, particularly in women's health, with a focus on therapies and treatments.

Johnson & Johnson

Johnson & Johnson is a diversified healthcare giant that competes across various segments, including pharmaceuticals relevant to Organon's market.

Amgen is a biopharmaceutical company that competes with Organon in the biosimilars market, offering alternative products.

Novo Nordisk is a global healthcare company that, through its biopharmaceutical products, competes with Organon in areas like hormone replacement therapies.

Teva- Pharmaceutical Industries

Teva Pharmaceutical Industries is a global leader in generic and specialty medicines, competing with Organon in the generics and women's health market.

Bristol-Myers Squibb

Bristol Myers Squibb is a global biopharmaceutical company that competes with Organon in developing and commercializing prescription pharmaceuticals.

GlaxoSmithKline is a global healthcare company that competes with Organon in pharmaceuticals and vaccines, including areas of women's health.

Sanofi is a global biopharmaceutical company focusing on human health, competing with Organon in healthcare solutions, including women's health.

About

Organon & Cois a globalised healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day. Its operations include the following product portfolios: Women's Health: Itbwomen's health portfolio of products is sold by prescription mainly in two therapeutic areas: contraception, with key brands such as Nexplanon, and fertility, with key brands such as Follistim. other women's health products include the Jada, which is intended to provide control and treatment of abnormal postpartum uterine bleeding or hemorrhage when conservative management is warranted. The General Medicines portfolio includes biosimilars and established brands. Companies' current biosimilars portfolio spans across immunology and oncology-related treatments.

Show more...

CEO

Joseph T. Morrissey Jr.

Employees

10000

Country

United States

Listings

0 Comments

Share your thoughts

FAQ

What is Organon stock ticker?▼

Depending on the exchange, the stock ticker may vary. For instance, on NYSE exchange Organon stocks are traded under the ticker OGN WI.

What is Organon revenue for the last year?▼

Organon revenue for the last year amounts to 6.4B USD.

What is Organon net income for the last year?▼

OGN WI net income for the last year is 864M USD.

How many employees does Organon have?▼

As of September 04, 2026, the company has 10,000 employees.

In which sector is Organon located?▼

Organon operates in the Health & Wellness sector.

When did Organon complete a stock split?▼

Organon has not had any recent stock splits.

Where is Organon headquartered?▼

Organon is headquartered in JERSEY CITY, United States.